News of Note—Designing a universal flu vaccine; detecting pancreatic cancer in blood

NIH scientists are testing new approaches to preventing the flu.

Making strides towards a universal flu vaccine

Scientists from the Vaccine Research Center at the NIH have discovered that by targeting the “stem” domain of the flu virus—rather than the highly variable “head” domain, as current vaccines do—they can induce a broad immune response against multiple strains of the virus. They believe the discovery, published in the journal Science Immunology, could inform efforts to develop a universal vaccine. (Science Immunology)

Detecting pancreatic cancer early


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Scientists at the University of Pennsylvania and the Mayo Clinic have identified two biomarkers in blood that can be used to detect the presence of pancreatic cancer. They believe their discovery could be turned into a blood test for the early detection and diagnosis of the disease in people deemed to be at high risk based on family history. (University of Pennsylvania)

New insight into HIV could yield fresh drug targets

NIH researchers have figured out that when HIV binds to the surface of a cell, it activates a protein called TMEM 16F, which allows it to infect the cells. They showed they could block this process chemically, thereby preventing the virus from invading the cell. This could lead to new drug targets in HIV, they believe. (NIH)

Suggested Articles

Combining AZ's MCL1 inhibitor AZD5991 with existing MEK or BRAF inhibitors could kill melanoma cells more effectively, scientists found.

Combining a checkpoint inhibitor with an anti-TFG-beta drug was effective in mouse models of metastatic prostate cancer, MD Anderson researchers said.

Blocking a newly discovered molecule produced by B cells could slow their flow into the brain and offer a new way to treat MS, a Canadian team found.